Hopscotch Primary Careが地方のプライマリケアを拡大するために5,300万ドルを調達

Why it matters

Hopscotch is testing whether technology and value-based contracts can make full-service primary-care clinics viable in rural markets that many healthcare businesses avoid. The Series D turns Kristin Myers Peng's regional model into a broader scaling test under Tim Gronniger, just as $50 billion in federal rural-health funding begins flowing through the states.

The rural primary-care network Kristin Myers Peng founded in 2021 raised a $53 million Series D to expand its clinic model beyond Western North Carolina, Hopscotch Primary Care said on August 18th.

Hopscotch Primary Care says it serves more than 15,000 patients through 12 locations across the Southeastern United States. Hopscotch plans to use the round to enter additional rural markets, add access within its existing region and scale the technology supporting its clinical operations.

The financing puts fresh capital behind Myers Peng's founding thesis: primary-care models developed for dense urban markets could be rebuilt around the workforce, distances and patient needs of rural communities. In a 2023 account of how Hopscotch began, Myers Peng wrote that rural patients were routinely overlooked because the problem was considered too difficult or easier opportunities existed elsewhere.

A biomedical engineer who later earned an MBA from Harvard Business School, Myers Peng worked in medical-device sales at Medtronic, venture capital and executive roles at Aetna, CVS Health and Unified Women's Healthcare before building Hopscotch. Her version of the model placed clinicians and care teams inside small communities, then used value-based payment contracts and software to give them longer-term responsibility for patients' health.

A founder's model enters its operating phase

Myers Peng led Hopscotch as CEO from September 2021 through June 2024. Hopscotch announced its $50 million Series C on June 28, 2024, and Myers Peng became chief operating officer of the Blue Cross Blue Shield Association that September. Hopscotch named Tim Gronniger CEO on November 13, 2024. His career has centered on moving providers from fee-for-service medicine into contracts tied to cost and outcomes.

Before Hopscotch, Gronniger was chief of value-based care at CVS Health subsidiary Signify Health and CEO of Caravan Health, which worked heavily with rural health systems. Hopscotch says Caravan and Signify supported more than 300 health systems and 26,000 clinicians serving over 1 million senior patients during his tenure. He previously held roles at the White House, the Centers for Medicare and Medicaid Services and Capitol Hill.

That background fits the next job Myers Peng's model requires. Opening clinics is expensive, local recruitment is slow and value-based care depends on managing medical costs across years rather than filling more appointment slots each day. Gronniger is taking a model proven in a limited regional footprint and attempting to reproduce it without weakening the patient relationships on which its economics depend.

8VC and Town Hall Ventures led the Series D. Existing backers aMoon Fund, Citi Impact Fund, Alumni Ventures and K2 HealthVentures also participated.

New investors include the Autism Impact Fund, Kleiner Perkins chairman John Doerr, Heritage Provider Network founder Richard Merkin and the Leon Levine Foundation. The Series C and Series D account for at least $103 million in publicly announced financing since June 2024. Hopscotch did not disclose a valuation for the latest round.

The technology has to make the clinics work

Hopscotch operates care sites rather than selling software to existing practices. Its patient model includes longer appointments, same-day access, multidisciplinary care teams and help coordinating medication, specialists, insurance and services outside the clinic. The main patient base is older adults covered by Medicare, Medicare Advantage or Medicare and Medicaid.

Hopscotch describes its technology in practical terms: reducing paperwork, identifying patients who need outreach and giving clinicians information to manage a population between visits. The financing announcement also introduced AI as part of that operating layer. Doerr said the goal was to help clinicians care for more patients while preserving the relationships at the center of primary care.

That positioning separates Hopscotch from rural-health businesses built mainly around telehealth or software enablement. Main Street Health supplies value-based-care infrastructure to existing practices, while Homeward combines mobile, virtual and in-person services. Hopscotch is making the capital-heavier wager that owning the clinic experience produces tighter control over patient access, clinical workflows and medical spending.

Hopscotch says patient retention remains above 90%, its Net Promoter Score is 89 and its management of medical expenses has improved medical-loss ratios by more than 25 percentage points during a patient's first two years. Hopscotch also says its Western North Carolina operations are profitable.

Those are company-reported figures. The announcement does not provide the patient cohorts, payer mix or methodology behind the measurements, and profitability in one region does not establish that a new market will mature on the same schedule. The Series D gives Gronniger room to test whether Hopscotch can repeat those claimed results as it recruits clinicians and opens clinics farther from its original base.

Federal money changes the timing

Hopscotch is raising as states begin deploying a large pool of public funding aimed at many of the same problems. The CMS Rural Health Transformation Program will distribute $50 billion from 2026 through 2030 for workforce recruitment, new access points, value-based care, digital tools and rural health infrastructure.

Hopscotch's financing is private capital rather than a CMS award, but state spending can create partners, infrastructure and demand around the regions Hopscotch wants to enter. It can also finance competing providers and technology vendors pursuing the same rural patients.

For Gronniger, the opening is unusually clear. Federal dollars are moving toward rural delivery, investors are again funding clinic-based models, and AI gives every healthcare operator a fresh efficiency pitch. Hopscotch still has to show that its software can lower the cost of delivering relationship-heavy medicine across dispersed towns. The $53 million round buys the clinics, clinicians and operating time needed to find out.